Decreased metastatic potential of breast cancer cells with diminished PANX1 activity prompted us to assess, using Real-Time Cell Analysis (RTCA), the invasive capacity of MDA-MB-231 cells, upon PBN treatment, and that of MDA-PANX1- cells. This evidence concerns the gene PANX1 and breast cancer.